Introducing Point-of-Care Imaging
for Wound Care

The leading point-of-care wound imaging devices for the detection of the presence and location of elevated bacterial loads and for accurate digital wound measurement.

MolecuLight i:X 

 Wound Imaging Device

The MolecuLight i:X allows clinicians to quickly, safely and easily visualize bacteria and measure wounds at the point of care.

Focused

Allows clinicians to focus on harmful bacteria with the guidance of fluorescence imaging.1,3,4

Efficient

Immediately know where to sample, where to debride and/or if you need an expensive antimicrobial product.1,6,7

No Contact

No contrast agents and no patient contact required.2

Point-of-Care

Instantly detects and reveals location of potentially harmful levels of bacteria. Wound area is also easily calculated on the i:X5,8.

Precise

Allows for more targeted treatment protocols by knowing exactly where fluorescent bacteria are.3,4

Ease of Use

Portable, touch-screen with an intuitive interface.1,2

What does MolecuLight i:X do?

Visualise Bacteria

MolecuLight i:X allows clinicians to focus on potentially harmful levels of bacteria with the guidance of fluorescence imaging.6,9,10

Measure Wound Area

MolecuLight i:X provides clinicians with a comprehensive toolkit for digital wound area measurement and documentation.

New peer-reviewed publications featuring MolecuLight appeared in:

Book a Demo

Ready to see moleculight in action and transform your woundcare business? Contact NuAngle Medical, the official distributor of Moleculight throughout Southern Africa.

References

1 American Diabetes Society, Diagnosis and Management of Diabetic Foot Infections, 2020
2 Heather L. Orsted et al., Foundations of Best Practice for Skin and Wound Management Skin: Anatomy, Physiology and Wound Healing
3 Robson MC et al., Guidelines for the treatment of venous ulcers. Wound Repair Regen. 2006 Nov-Dec;14(6):649-62
4 Emily Haesler et al., National Pressure Ulcer Advisory Panel, European Pressure Ulcer Advisory Panel and Pan Pacific Pressure Injury Alliance. Prevention and Treatment of Pressure Ulcers: Clinical Practice Guideline, 2014
5 O’Donnell TF et al., Society for Vascular Surgery; American Venous Forum. Management of venous leg ulcers: clinical practice guidelines of the Society for Vascular Surgery, J Vasc Surg. 2014 Aug;60(2 Suppl):3S-59S
6 American Diabetes Society Diagnosis and Management of Diabetic Foot Infections, 2020
7 Emily Haesler et al., National Pressure Ulcer Advisory Panel, European Pressure Ulcer Advisory Panel and Pan Pacific Pressure Injury Alliance. Prevention and Treatment of Pressure Ulcers: Clinical Practice Guideline, 2014
8 Connie L. Harris et al., Best Practice Recommendations for the Prevention and Management of Surgical Wound Complications
10 Martin C. Robson et al., Guidelines for the treatment of venous ulcers
11 O’Donnell TF Jr et al., Society for Vascular Surgery; American Venous Forum. Management of venous leg ulcers: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2014 Aug;60(2Suppl):3S-59S
12 Ousey K. et al., International Consensus Document: Identifying and treating foot ulcers in patients with diabetes: saving feet, legs and lives. J Wound Care 2018; 27
13, 19, 23 Emily Haesler et al., National Pressure Ulcer Advisory Panel, European Pressure Ulcer Advisory Panel and Pan Pacific Pressure Injury Alliance. Prevention and Treatment of Pressure Ulcers: Clinical Practice Guideline, 2014
14 Hopf HW et al., Guidelines for the treatment of arterial insufficiency ulcers. Wound Repair Regen. 2006 Nov-Dec;14(6):693-710
15, 16, 20 Whitney J, et al., Guidelines for the treatment of pressure ulcers. Wound Repair Regen. 2006 Nov-Dec;14(6):663-79
21 Atkin L. et al., Implementing TIMERS: the race against hard-to-heal wounds. J Wound Care 2019; 28(3 Suppl 3):S1–S49